Engineered heparins as new anticoagulant drugs D Vaidyanathan, A Williams, JS Dordick, MAG Koffas, RJ Linhardt Bioengineering & translational medicine 2 (1), 17-30, 2017 | 44 | 2017 |
Metabolic engineering of Bacillus megaterium for heparosan biosynthesis using Pasteurella multocida heparosan synthase, PmHS2 A Williams, KS Gedeon, D Vaidyanathan, Y Yu, CH Collins, JS Dordick, ... Microbial cell factories 18, 1-13, 2019 | 38 | 2019 |
Heavy heparin: a stable isotope‐enriched, chemoenzymatically‐synthesized, poly‐component drug BF Cress, U Bhaskar, D Vaidyanathan, A Williams, C Cai, X Liu, L Fu, ... Angewandte Chemie 131 (18), 6023-6027, 2019 | 37 | 2019 |
Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase D Vaidyanathan, E Paskaleva, T Vargason, X Ke, SA McCallum, ... Glycobiology 30 (11), 847-858, 2020 | 10 | 2020 |
Polysaccharide sequence influences the specificity and catalytic activity of Glucuronyl C5-epimerase D Vaidyanathan, X Ke, Y Yu, RJ Linhardt, JS Dordick Biochemistry 59 (27), 2576-2584, 2020 | 3 | 2020 |
Effects of Ag/adjuvant ratio on the systemic and mucosal antibody responses of BALB/c mice immunized intradermally with CfaEB, a minor-major subunit fusion of the … M Maciel, D Vaidyanathan, W Hulsey, S Savarino The Journal of Immunology 194 (1_Supplement), 145.12-145.12, 2015 | 1 | 2015 |
Characterization of the activity of glucuronyl C5-epimerase D Vaidyanathan, X Ke, R Linhardt, J Dordick ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
Hydrogen-deuterium exchange to interrogate the reaction kinetics of d-glucuronyl C5 epimerase D Vaidyanathan, L Lin, K St Ange, X Zhang, B Cress, C Wang, R Linhardt, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
Engineering D-glucuronyl C5-epimerase for increased enzyme solubility and activity D Vaidyanathan, E Paskaleva, G Makhatadze, J Dordick, R Linhardt ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |